Higher MDMX expression was associated with hypomethylating agent resistance and inferior survival in MDS patients, inferring it a potential therapeutic target

Yu-Hung Wang; Chien-Chin Lin; Kristian Gurashi; Bettina Wingelhofer; Fabio M R Amaral; Chi-Yuan Yao; Hsin Ting Hsieh; Ming Chih Liu; Hsin-An Hou; Wen-Chien Chou; Kiran Batta; Daniel H Wiseman; Hwei-Fang Tien

doi:10.1038/s41375-023-02044-2

Higher MDMX expression was associated with hypomethylating agent resistance and inferior survival in MDS patients, inferring it a potential therapeutic target

Yu-Hung Wang, Chien-Chin Lin, Kristian Gurashi, Bettina Wingelhofer, Fabio M R Amaral, Chi-Yuan Yao, Hsin Ting Hsieh, Ming Chih Liu, Hsin-An Hou, Wen-Chien Chou, Kiran Batta, Daniel H Wiseman, Hwei-Fang Tien

National Taiwan University Hospital

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	2507-2511
Number of pages	5
Journal	Leukemia
Volume	37
Issue number	12
Early online date	2 Nov 2023
DOIs	https://doi.org/10.1038/s41375-023-02044-2
Publication status	Published - Dec 2023

Keywords

Humans
Myelodysplastic Syndromes/drug therapy
Prognosis
Azacitidine/pharmacology

Access to Document

10.1038/s41375-023-02044-2

Cite this

Wang, Y.-H., Lin, C.-C., Gurashi, K., Wingelhofer, B., Amaral, F. M. R., Yao, C.-Y., Hsieh, H. T., Liu, M. C., Hou, H.-A., Chou, W.-C., Batta, K., Wiseman, D. H., & Tien, H.-F. (2023). Higher MDMX expression was associated with hypomethylating agent resistance and inferior survival in MDS patients, inferring it a potential therapeutic target. Leukemia, 37(12), 2507-2511. https://doi.org/10.1038/s41375-023-02044-2

@article{5e9dab9086984524a1748151d354d8fb,

title = "Higher MDMX expression was associated with hypomethylating agent resistance and inferior survival in MDS patients, inferring it a potential therapeutic target",

keywords = "Humans, Myelodysplastic Syndromes/drug therapy, Prognosis, Azacitidine/pharmacology",

author = "Yu-Hung Wang and Chien-Chin Lin and Kristian Gurashi and Bettina Wingelhofer and Amaral, {Fabio M R} and Chi-Yuan Yao and Hsieh, {Hsin Ting} and Liu, {Ming Chih} and Hsin-An Hou and Wen-Chien Chou and Kiran Batta and Wiseman, {Daniel H} and Hwei-Fang Tien",

year = "2023",

month = dec,

doi = "10.1038/s41375-023-02044-2",

language = "English",

volume = "37",

pages = "2507--2511",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "12",

}

Wang, Y-H, Lin, C-C, Gurashi, K, Wingelhofer, B, Amaral, FMR, Yao, C-Y, Hsieh, HT, Liu, MC, Hou, H-A, Chou, W-C, Batta, K, Wiseman, DH & Tien, H-F 2023, 'Higher MDMX expression was associated with hypomethylating agent resistance and inferior survival in MDS patients, inferring it a potential therapeutic target', Leukemia, vol. 37, no. 12, pp. 2507-2511. https://doi.org/10.1038/s41375-023-02044-2

TY - JOUR

T1 - Higher MDMX expression was associated with hypomethylating agent resistance and inferior survival in MDS patients, inferring it a potential therapeutic target

AU - Wang, Yu-Hung

AU - Lin, Chien-Chin

AU - Gurashi, Kristian

AU - Wingelhofer, Bettina

AU - Amaral, Fabio M R

AU - Yao, Chi-Yuan

AU - Hsieh, Hsin Ting

AU - Liu, Ming Chih

AU - Hou, Hsin-An

AU - Chou, Wen-Chien

AU - Batta, Kiran

AU - Wiseman, Daniel H

AU - Tien, Hwei-Fang

PY - 2023/12

Y1 - 2023/12

KW - Humans

KW - Myelodysplastic Syndromes/drug therapy

KW - Prognosis

KW - Azacitidine/pharmacology

UR - http://www.scopus.com/inward/record.url?scp=85175624808&partnerID=8YFLogxK

U2 - 10.1038/s41375-023-02044-2

DO - 10.1038/s41375-023-02044-2

M3 - Article

C2 - 37919605

SN - 0887-6924

VL - 37

SP - 2507

EP - 2511

JO - Leukemia

JF - Leukemia

IS - 12

ER -

Higher MDMX expression was associated with hypomethylating agent resistance and inferior survival in MDS patients, inferring it a potential therapeutic target

Keywords

Access to Document

Other files and links

Cite this